Beyond the Journal: The science of communication – Communicating vaccine research in a pandemic

Input square image here

2nd Sept 2021

Ruth Francis

Asia Research News

@ResearchSEA

University of Oxford and their partner AstraZeneca, developed one of the first COVID-19 vaccines. The Oxford University vaccine team has been part of an astonishing story that shifted both global management of COVID-19 and changed vaccinology forever.

Ruth Francis spoke to Steve Pritchard, strategic communications manager at the University of Oxford, about how they managed the intense, ongoing coverage.

As we live through the COVID-19 pandemic, health and medical research remains at the top of the news agenda. For media officers, particularly those at institutions working on COVID, the pressure has been intense.

At the University of Oxford, researchers developed one of the first COVID-19 vaccines approved, and their partners AstraZeneca pledged to make no profit on the vaccine during the pandemic. The team has been part of an astonishing story that has shifted both global management of COVID-19 and changed vaccinology forever. We spoke to Steve Pritchard, strategic communications manager at the University of Oxford, about how Steve managed the intense, ongoing coverage.

Read the full article at Asia Research News